Young people with diabetes may have a significantly higher risk of developing Alzheimer’s disease later in life, according to a new study by researchers in the Lifecourse Epidemiology of Adiposity and Diabetes (LEAD) Center at the University of Colorado Anschutz Medical Campus.
(Glucagon + insulin human) by Abvance Therapeutics for Hypoglycemia: Likelihood of Approval
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes
July 1, 2023